ZHONGCHAO INC-CLASS A
ZCMDNASDAQTrading Snapshot
- Day Range
- $1.13 β $1.14
- 52-Week Range
- $1.08 β $1,443.36
- Volume (shares)
- 562
- Avg Volume (shares)
- β
- Shares Outstanding
- 4.4M
- Next Earnings
- β
Fundamentals Snapshot
- Annual Revenue
- $11M
- Last Q Revenue
- $6M
- P/E Ratio
- β
- P/S Ratio
- 0.5x
- EPS (TTM)
- $-328.03
- Dividend Yield
- β
- Dilution (1yr)
- +496.5%
ZHONGCHAO INC-CLASS A
ZCMDAbout ZHONGCHAO INC-CLASS A
Zhongchao Inc. provides healthcare information, education, and training services to healthcare professionals under their MDMOOC brand in the People's Republic of China. It operates through two segments, MDMOOC services, and Sales of Patented Drugs. The company offers patient management services in the tumor and rare diseases field, internet healthcare services, and pharmaceutical services, and operates an online information platform. It also provides online and onsite health information services, healthcare education programs, and healthcare training products, including clinical practice training, open classes on popular medical topics, interactive case studies, academic conferences and workshops, continuing education courses, and articles and short videos with educational healthcare content. The company offers its services through its MDMOOC online platform, such as the MDMOOC mobile app, MOOC Medical WeChat subscription account, and MDMOOC website, and patient management services through an IT system under the Zhongxun brand, WeChat mini program, and Zhongxin Health WeChat mini program. It serves pharmaceutical enterprises and non-profit organizations, including medical associations, medical institutions, medical journals, medical foundations, and hospitals, as well as healthcare professionals, nurses, and doctors. Zhongchao Inc. was founded in 2012 and is headquartered in Shanghai, China.
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Insufficient data for all five components.
Latest News & Updates
News unavailable.